Hip Exoskeleton for COPD

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Nebraska
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

1\) Purpose: To improve pulmonary rehabilitation outcomes for individuals with COPD by evaluating the effectiveness of a hip-assisted exoskeleton during a single pulmonary rehabilitation session. 2) Eligibility criteria: Participants must be between 45-75 years old, any gender, but must have a BMI of less than 35 kg/m\^2, free from co-morbidities that may affect walking patterns, and must have moderate to severe COPD with no other pulmonary or cardiac issues. (Eligible participants will undergo a screening process which includes 6-minute walking test, medical history exam, and spirometry evaluation.) 3) Intervention and evaluation: The experimental collection will be conducted at the Biomechanics Research Building at the University of Nebraska at Omaha. Participants are required to participate in two sessions on two separate days, both including a 30-minute walking session with one session wearing the hip exoskeleton and the other session without the device.

Are You a Good Fit for This Trial?

This trial is for people aged 45-75 with moderate to severe COPD, a BMI under 35, and no other lung or heart problems. Participants must be able to walk without issues from other health conditions.

Inclusion Criteria

I am between 45 and 75 years old.
Must undergo post-bronchodilator spirometry, pass screening protocol, and receive formal physician clearance for participation
BMI less than 35 kg/m^2
See 1 more

Exclusion Criteria

Failing to pass the initial spirometry test
I have a lung or heart problem that makes treadmill exercise unsafe for me.
My doctor has not approved me to join this study.

What Are the Treatments Tested in This Trial?

Interventions

  • Hip Exoskeleton-Assisted Walking

Trial Overview

The study tests if using a hip exoskeleton during a single walking session can help improve breathing and exercise ability in people with COPD. Each participant tries walking both with and without the device on separate days.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Hip Exoskeleton-Assisted WalkingExperimental Treatment1 Intervention
Group II: Standard Walking (No Hip Exoskeleton)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Nebraska

Lead Sponsor

Trials
563
Recruited
1,147,000+